| A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid Arthritis (NCT01754805) | Astellas Pharma Inc | 2010-01-22 |
| Avenir Müller Hip Stem Post Market Surveillance Study (NCT04079127) | Zimmer Biomet | 2010-01-09 |
| A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis (NCT01050998) | MedImmune LLC | 2010-01-05 |
| Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis (NCT02368093) | Taichung Veterans General Hospital | 2010-01-01 |
| Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction (NCT03382665) | Zimmer Biomet | 2010-01-01 |
| An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS) (NCT01185522) | Hoffmann-La Roche | 2010-01-01 |
| Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA) (NCT01198509) | NYU Langone Health | 2010-01-01 |
| Dose Escalation With Remicade® and Orencia® (NCT01141413) | Bristol-Myers Squibb | 2010-01-01 |
| Local Analgesia in Knee- and Hipatroplastic Surgery in Patients With Rheumatic Disease: Extra- vs. Intracapsulare Position of Catheter (NCT01050738) | Spenshult Hospital | 2010-01-01 |
| Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis (NCT00995449) | Humanigen, Inc. | 2010-01-01 |
| Use of Thermal and 3D Imaging to Quantify Arthritis (NCT01044823) | University of Pittsburgh | 2010-01-01 |
| Curcumin in Rheumatoid Arthritis (NCT00752154) | University of California, Los Angeles | 2010-01-01 |
| Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS) (NCT02731560) | Prof. Abid Z. Farooqi | 2010-01-01 |
| An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis (NCT01071798) | Hoffmann-La Roche | 2010-01-01 |
| A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT01089023) | Hoffmann-La Roche | 2010-01-01 |
| A Randomised Trial Comparing Anterior Versus Posterior Approach in Total Hip Replacement (NCT01106560) | Medacta International SA | 2010-01-01 |
| A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid Arthritis (NCT01034137) | Hoffmann-La Roche | 2010-01-01 |
| Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate (NCT00950989) | Amgen | 2009-12-30 |
| Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis (NCT01000441) | University Hospital, Strasbourg, France | 2009-12-23 |
| Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis (NCT01027728) | Amgen | 2009-12-01 |
| Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis (NCT01163318) | AbbVie (prior sponsor, Abbott) | 2009-12-01 |
| Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers (NCT01029613) | Glostrup University Hospital, Copenhagen | 2009-12-01 |
| Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis (NCT01023256) | MorphoSys AG | 2009-12-01 |
| Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists (NCT01040715) | Neovacs | 2009-12-01 |
| A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis (NCT01044498) | Hoffmann-La Roche | 2009-12-01 |
| Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients (NCT01001832) | Bristol-Myers Squibb | 2009-12-01 |
| Total Knee Arthroplasty (TKA) Cemented Versus Cementless Tibial Prosthesis Study (NCT01041937) | Washington University School of Medicine | 2009-12-01 |
| Predictors of Adherence to Orencia (NCT01136707) | Bristol-Myers Squibb | 2009-12-01 |
| A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis (NCT00976599) | Pfizer | 2009-11-01 |
| Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis Patients (NCT01137851) | Bristol-Myers Squibb | 2009-11-01 |
| Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants (NCT01009879) | University of Pittsburgh | 2009-11-01 |
| 2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use (NCT01284283) | Encore Medical, L.P. | 2009-11-01 |
| Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy (NCT00844714) | University of California, San Francisco | 2009-11-01 |
| SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (NCT01010581) | 4SC AG | 2009-11-01 |
| Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid Arthritis (NCT01007175) | Ablynx, a Sanofi company | 2009-11-01 |
| A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs. (NCT00996203) | Hoffmann-La Roche | 2009-10-31 |
| A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT00951275) | Hoffmann-La Roche | 2009-10-31 |
| A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis (NCT01007435) | Hoffmann-La Roche | 2009-10-31 |
| Vanguard Rocc Post Market Surveillance (NCT03664791) | Zimmer Biomet | 2009-10-23 |
| A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis (NCT00938587) | Pfizer | 2009-10-07 |
| Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis (NCT01002716) | Tel-Aviv Sourasky Medical Center | 2009-10-01 |
| Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis Patients (NCT01123655) | VA Office of Research and Development | 2009-10-01 |
| Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis (NCT01211834) | JW Pharmaceutical | 2009-10-01 |
| Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation (NCT01120366) | SURPRISE Study Group | 2009-10-01 |
| A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs (NCT00996606) | Hoffmann-La Roche | 2009-10-01 |
| A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis (NCT00993317) | Korea Otsuka Pharmaceutical Co., Ltd. | 2009-10-01 |
| Vanguard Complete Knee Versus Vanguard High Flex Rotating Platform (RP) Knee Study (NCT01010269) | Zimmer Biomet | 2009-10-01 |
| Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis (NCT01873625) | Royan Institute | 2009-10-01 |
| Improvement of a Physically Active Lifestyle (NCT00979719) | Freie Universität Berlin | 2009-10-01 |
| Abatacept Versus Adalimumab Head-to-Head (NCT00929864) | Bristol-Myers Squibb | 2009-10-01 |
| Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic Agents (NCT01137838) | Bristol-Myers Squibb | 2009-10-01 |
| To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate (NCT01009242) | UCB Pharma | 2009-10-01 |
| Genetics and Mechanisms of Rheumatoid Arthritis (NCT01788098) | Slovak Academy of Sciences | 2009-10-01 |
| Observation of Treatment With Certolizumab Pegol in Daily Practice (NCT01069419) | UCB Pharma GmbH | 2009-10-01 |
| A Study for Japanese Participants With Rheumatoid Arthritis (RA) (NCT01253226) | Eli Lilly and Company | 2009-09-01 |
| Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines (NCT00993668) | UCB Pharma | 2009-09-01 |
| Improving Beliefs About Medication in Patients With Rheumatoid Arthritis (NCT00968266) | Sint Maartenskliniek | 2009-09-01 |
| Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis (NCT00913458) | Pfizer | 2009-09-01 |
| Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis (NCT00969527) | Catalysis SL | 2009-09-01 |
| National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs) (NCT01095393) | UCB Pharma | 2009-09-01 |
| Lifestyle Interventions Based on the Mediterranean Diet for Patients With Rheumatoid Arthritis (NCT02028624) | Harokopio University | 2009-09-01 |
| Self-Directed Exercise Program for Adults With Arthritis (NCT01172327) | University of South Carolina | 2009-09-01 |
| An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab) (NCT01075477) | Hoffmann-La Roche | 2009-09-01 |
| Targeting Synovitis in Early Rheumatoid Arthritis (NCT00920478) | NHS Greater Glasgow and Clyde | 2009-09-01 |
| Atherosclerosis in Rheumatoid Arthritis (NCT00990730) | University of California, San Francisco | 2009-09-01 |
| Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment (NCT00984815) | Amgen | 2009-09-01 |
| Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment (NCT00929357) | Pfizer | 2009-08-01 |
| Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component (NCT03681639) | Zimmer Biomet | 2009-08-01 |
| Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate (NCT01224041) | Astellas Pharma Inc | 2009-08-01 |
| Rheumatology Clinical Registry (NCT01813409) | American College of Rheumatology | 2009-08-01 |
| Comparison of Three Different Treatment Regimes in Early Rheumatoid Arthritis: A Randomized Open-labelled Trial (NCT01870128) | All India Institute of Medical Sciences | 2009-08-01 |
| A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis (NCT00965653) | Hoffmann-La Roche | 2009-08-01 |
| A Study in Patients With Rheumatoid Arthritis (NCT00966875) | Eli Lilly and Company | 2009-08-01 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (NCT00965757) | Eisai Co., Ltd. | 2009-07-31 |
| Rheumatoid Arthritis Coping Enhancement (NCT04246827) | Duke University | 2009-07-07 |
| Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate (NCT00903383) | Lexicon Pharmaceuticals | 2009-07-01 |
| Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX) (NCT00928512) | Novartis Pharmaceuticals | 2009-07-01 |
| Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy (NCT01083563) | University of Rochester | 2009-07-01 |
| An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab (NCT02507752) | Hoffmann-La Roche | 2009-07-01 |
| Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis (NCT00883896) | Pfizer | 2009-06-18 |
| Participation Restrictions in Rheumatoid Arthritis (NCT02863653) | Federal University of Minas Gerais | 2009-06-01 |
| Activity Limitations in Rheumatoid Arthritis (NCT02730286) | Federal University of Minas Gerais | 2009-06-01 |
| Occupational Performance Problems in Individuals With Rheumatoid Arthritis (NCT02968745) | Federal University of Minas Gerais | 2009-06-01 |
| The Use of Neuromuscular Electrical Stimulation to Reverse Muscle Atrophy in Patients With Rheumatoid Arthritis (NCT00924625) | University of Pittsburgh | 2009-06-01 |
| Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs (NCT00947492) | Assistance Publique Hopitaux De Marseille | 2009-06-01 |
| First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis (NCT00927927) | Janssen Research & Development, LLC | 2009-06-01 |
| Evaluation of the BRADA and ABILHAND Questionnaires (NCT00938444) | University Hospital, Ghent | 2009-06-01 |
| Applications for Methotrexate Optimization in Rheumatoid Arthritis (NCT01038349) | Cypress Bioscience, Inc. | 2009-06-01 |
| A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis. (NCT01010503) | Hoffmann-La Roche | 2009-06-01 |
| Iyengar Yoga for Young People With Rheumatoid Arthritis (NCT01096823) | University of California, Los Angeles | 2009-06-01 |
| Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy (NCT00848354) | Pfizer | 2009-06-01 |
| TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNF (NCT00977106) | Hoffmann-La Roche | 2009-06-01 |
| Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept (NCT01388608) | University Hospital Muenster | 2009-06-01 |
| An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor (NCT01557348) | Hoffmann-La Roche | 2009-06-01 |
| Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis (NCT00838565) | Pfizer | 2009-05-20 |
| A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA) (NCT00902369) | Asahi Kasei Therapeutics Corporation | 2009-05-01 |
| Evaluation by HR-pQCT of Bone Microarchitecture Changes in Patients With Rheumatoid Arthritis Under Anti-TNF Therapy. (NCT02526992) | Centre Hospitalier Universitaire de Saint Etienne | 2009-05-01 |
| INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs (NCT00902486) | Incyte Corporation | 2009-05-01 |
| Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs) (NCT01136694) | Bristol-Myers Squibb | 2009-05-01 |
| A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis (NCT00853385) | Pfizer | 2009-05-01 |